Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Alnylam Pharmaceuticals Stock (NASDAQ: ALNY) stock price, news, charts, stock research, profile.

Open	$275.39
Close	$273.88
Volume / Avg.	907.22K / 1.20M
Day Range	$270.17 - $275.39
52 Wk Range	141.98 - 287.55
Market Cap	$35.16B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	3.38%
Days to Cover	3.56

Recent News

ALNY Down Despite Positive Data From Heart Disease Drug Study

Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) were down 8.5% on Aug. 30, after the company announced detailed data from the phase III HELIOS-B, which evaluated its investigational RNAi therapeutic, Amvuttra (vutrisiran) for an expanded indication.

Zacks

Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles

Alnylam Pharmaceuticals shares drop as detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR-CM reveal mixed outcomes. Reductions in mortality and cardiovascular events were presented at ESC Congress 2024. Regulatory submissions remain on track.

Vandana Singh

DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H. Robinson Worldwide, and DoorDash.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Alnylam Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Who are Alnylam Pharmaceuticals (ALNY) competitors?

Other companies in Alnylam Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

There is no analysis for Alnylam Pharmaceuticals to provide a consensus price target.

What is the current price for Alnylam Pharmaceuticals (ALNY)?

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $273.88 last updated September 20, 2024 at 4:39 PM EDT.

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

There are no upcoming dividends for Alnylam Pharmaceuticals.

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

Alnylam Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Alnylam Pharmaceuticals (ALNY) going to split?

There is no upcoming split for Alnylam Pharmaceuticals.

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now